Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. (ALDX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
aldx · stock forecast · 19 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 19 Wall Street analysts in the past 3 months
Buy
19 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$12.00
Consensus
$9.67
+452.6% upside
Low
$7.00
Median: $10 · Last Close: $1.75
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$9.67
452.6% upside
High Target
$12
585.7%
Low Target
$7
300.0%
Current Price
$1.75
as of today
Based on analyst price targets, the ALDX stock price prediction for the next 12 months ranges from $7 to $12. The consensus ALDX price forecast of $9.67 implies 452.6% upside from the current price of $1.75.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.78 | ↑ 1.86% |
1-day model range: $1.77–$1.8. Peak: $1.8 (+1.86%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ALDX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-18 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-11-10 | BTIG | Maintains | Buy→Buy |
| 2025-05-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-07 | BTIG | Maintains | Buy→Buy |
| 2025-04-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-06 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Aldeyra Therapeutics, Inc. (ALDX) stock. Of the recent 51 rating actions, 1 were upgrades and 2 were downgrades. 19 analysts currently cover ALDX.
Analyst Recommendation Trends
ALDX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$22M
↓ 90.5% YoY
Revenue Next Year
$11M
↓ 48.4% YoY
EPS This Year
$-0.41
EPS Next Year
$-0.21
↓ 49.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ALDX EPS of $-0.41 for the current fiscal year, based on estimates from 2 analysts. The ALDX revenue forecast is $22M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ALDX stock forecast is supported by two independent data sources: analyst consensus ratings from 19 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ALDX price target is $9.67 (+452.6% upside), with an analyst consensus of Buy.
The ALDX short-term stock prediction for tomorrow is $1.78 (+1.86%).
Aldeyra Therapeutics, Inc. trades on NASDAQ under the ticker ALDX. The ALDX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 95% of covering analysts.
Frequently asked questions
ALDX forecast · 8 questionsAccording to 19 Wall Street analysts, the average 12-month ALDX price target is $9.67, with a high forecast of $12.00 and a low of $7.00. The median price target is shown in the chart above when available. This implies +452.6% potential upside from the current price of $1.75.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.